SCHEMBL17494121

SCHEMBL17494121

ClC=CCn1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16079088 0.78
SCHEMBL3308860 0.78
SCHEMBL11412963 0.78
SCHEMBL27176240 0.77 FDPS (0.35)
SCHEMBL28243388 0.77 FDPS (0.35)
SCHEMBL15900310 0.75 HDAC1 (0.39)
SCHEMBL1990724 0.75
SCHEMBL23264871 0.74 FDPS (0.33)
SCHEMBL28530484 0.74 TSHR (0.35)
SCHEMBL16076616 0.74 FDPS (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49517-E1 Pyrazoles Janssen Pharmaceuticals, Inc. (US) 2023-05-02 US disclosed
EP-3180315-B1 PYRAZOLES JANSSEN PHARMACEUTICALS INC (US) 2020-03-18 EP disclosed
US-10155727-B2 Pyrazoles Janssen Pharmaceuticals, Inc. (US) 2018-12-18 US disclosed
US-20170275254-A1 PYRAZOLES JANSSEN PHARMACEUTICALS INC (US) 2017-09-28 US disclosed
EP-3180315-A1 PYRAZOLES Janssen Pharmaceuticals, Inc. (US) 2017-06-21 EP disclosed
WO-2016025918-A1 PYRAZOLES Janssen Pharmaceuticals, Inc. (US) 2016-02-18 WO disclosed